Regional footprint Italy-based IBSA Farmaceutici Italia Srl operates multiple manufacturing sites near Milan, a head office in Lodi, and a branch in Rome, offering a broad European distribution and potential for regional supply contracts, co-development, or contract manufacturing agreements.

Diverse portfolio Portfolio spans prescription drugs, OTC products, medical devices and food supplements across ten therapeutic areas, presenting opportunities to cross-sell to existing distributors, expand into adjacent markets, or partner on new formulations and line extensions.

Innovation engine Strategic focus on innovation with collaborations such as In Silico Trials and new product launches (Class40, BabyHeART, Profhilo lines), making IBSA a candidate for collaborative R&D partnerships, digital health initiatives, and accelerated product development programs.

Global reach Active export to 90 countries and recent international launches (Australia, UK/Ireland), indicating readiness for global supply partnerships, regulatory support services, and scalable manufacturing capacity for overseas distribution.

Sustainability & quality Four-pillar philosophy—Person, Innovation, Quality, Responsibility—combined with private ownership and Italian manufacturing pride suggests strong alignment with customers prioritizing quality assurance, traceability, and sustainable supply chains in regulated markets.